Charting the rise in antimicrobial resistance
We look at the data behind antibiotic drug discovery and development, bacterial resistance and the financial problems with the current business model
The supply of new antibiotics used to be plentiful, but the pace has slowed drastically since the 1980s. At the same time, bacteria have developed resistance to the existing drugs, resulting in increasing deaths. In this article we look at the data behind antibiotic discovery and development, bacterial resistance and the financial problems with the current business model